Abstract

Asmaa Barkat* and Amina Barkat

ABSTRACT

Background: If eclampsia is the second direct cause of maternal deaths in the international and national levels, Kenitra made except by recording this complication as a leading cause of maternal deaths in the province, with a percentage of 42.9%. An alarming figure that intersects with an underutilization of magnesium sulfate (SO4Mg), despite its importance in improving the health status of pre-eclamptic and eclamptic women. The objective of this work: Describe the factors associated with the underutilization of magnesium sulfate by midwives, nurse midwife and doctors from the six birthing centers in Kenitra province during the 2010-2014 period. Materials and Methods: With exhaustive sampling, this study used two measuring instruments. On the one hand, a self-administered questionnaire with 32 people, with a response rate of 100%. On the other hand, interviews with a responsible of the reference maternity of kenitra, a resuscitator of the provincial hospital, and a resource person at the network of basic health care in Kenitra. Results: According to the results of this study, 71.43% of participants do not use magnesium sulfate, against only 28.57% who use it. And among those they use 38.10% reported their dissatisfaction with its use. This is due to a number of factors: a) team dynamics and interpersonal relationships that occurred in 52.38% of responses. b) The need for quality continuing education raised by 52.38%. c) The perception of magnesium sulfate as a danger illustrated in 80.95%. d) The fear of this drug noted in 61, 90%. e) The medico-legal reasons identified in 61.91% of the answers as factors in the non-use of magnesium sulfate. f) The non-existence of a law authorizing its use in 95.24%. g) The legal framework for the practice of midwives in 85.72%. h) The risk of legal proceedings reported by 61.91%. i) The effective of staff is recorded in 80.95%. j) The working conditions raised at 71, 43%. k) The non-involvement of doctors in the decision to use this drug in 66.67%. l) The quality of communication between the delivery house and the reference maternity in 52.38% And, m) transfer barriers advanced by 71.43% of participants in this study. Conclusion: Since magnesium sulfate is an effective therapeutic that is at the forefront of anticonvulsants, the results of this study demonstrate the need to federate the government and local efforts to deal with its underutilization.